- Define and describe the etiology of subcutaneous adipose tissue (SAT) presentation in a nodular, fibrotic tissue fascia reticulum that is refractory to diuretics, weight loss, and directly associated with pain and hypermobility.
- Define and describe the definition and classification, with staging of Lipedema.
- Define and describe the treatment options with pharmacological interventions for Lipedema, including processes to reduce inflammation, and improve lymphatic system through reduction of excess leakage from capillaries, veins and lymphatic vessels.
- Access resources for Lipedema and other SAT disorders.
- Demonstrate commitment to using risk-benefit, cost-benefit, and evidence-based considerations in the selection for diagnostic and therapeutic interventions for adipose tissue variations, particularly Lipedema.
- Educate patients about the impact obesity has on their quality of life, well-being, ability to work, and family.
Dr. Karen Herbst has disclosed that she is on the speaker's board of Tactile Medical.
All other Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they do not have any relevant financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.
The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine - Tucson designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This course contains a 10-question assessment. The learner must complete the assessment with a passing score of 80%. You can reattempt the test if you do not pass on your initial attempt.